National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 34214-34215 [2020-11982]
Download as PDF
34214
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040M,
MSC 7806, Bethesda, MD 20892, 301–402–
7278, movsesyanv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cerebrovascular Disorders,
Traumatic Brain Injury and Epilepsy.
Date: July 1, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5211,
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR19–367:
Maximizing Investigators’ Research Award
(R35—Clinical Trial Optional).
Date: July 1, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: C–L Albert Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4146,
MSC 7806, Bethesda, MD 20892, 301–435–
1016, wangca@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 28, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11910 Filed 6–2–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK9F5VC42PROD with NOTICES
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
VerDate Sep<11>2014
20:12 Jun 02, 2020
Jkt 250001
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; FineMapping Genome-Wide Associated Loci to
Identify Proximate Causal Mechanisms of
Serious Mental Illness.
Date: June 24, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Genetic Architecture of Mental Disorders in
Ancestrally Diverse Populations.
Date: June 26, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Vinod Charles, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6151, MSC 9606,
Bethesda, MD 20892–9606, 301–443–1606,
charlesvi@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Rapid-Acting Interventions for Severe
Suicide Risk (R01).
Date: June 30, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–9734,
millerda@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Dated: May 28, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11913 Filed 6–2–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Career Development Program to Promote
Diversity in Health Research (K01).
Date: July 1, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH/NHLBI, 6705 Rockledge Drive,
Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Zhihong Shan, Ph.D., MD,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 205–J,
Bethesda, MD 20892, (301) 827–7985,
zhihong.shan@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Catalyze Review for Small Molecules
and Biologics.
Date: July 14, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH/NHLBI, 6705 Rockledge Drive,
Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Melissa E. Nagelin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–R,
Bethesda, MD 20892, (301) 827–7951,
nagelinmh2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
PPG Special Emphasis Panel.
Date: July 16, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health (NIH),
Rockledge 1, 6705 Rockledge Drive,
Bethesda, MD 22192 (Telephone Conference
Call).
E:\FR\FM\03JNN1.SGM
03JNN1
lotter on DSK9F5VC42PROD with NOTICES
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
Contact Person: Stephanie J. Webb, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–V,
Bethesda, MD 20892, (301) 827–7992,
stephanie.webb@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Mentored Career Development
Awards—K23, K24, K99.
Date: July 16, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKLI,
6705 Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Lindsay M. Garvin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 208–Y,
Bethesda, MD 20892, (301) 827–7911,
lindsay.garvin@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI Diversity Education Program.
Date: July 20, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Shelley S. Sehnert, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Suite 208–T,
Bethesda, MD 20892–7924, (301) 827–7984,
ssehnert@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Short Term Institutional Training Awards.
Date: July 23, 2020.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20872 (Telephone Conference Call).
Contact Person: Tony L. Creazzo, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 207–Q,
Bethesda, MD 20892–7924, (301) 827–7913,
creazzotl@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
R35 Outstanding Investigator Award.
Date: July 28–29, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH/NHLBI, 6705 Rockledge Drive,
Bethesda, MD 20814 (Telephone Conference
Call).
Contact Person: Kristen Page, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 209–B,
Bethesda, MD 20892, (301) 827–7953,
kristen.page@nih.gov.
VerDate Sep<11>2014
20:12 Jun 02, 2020
Jkt 250001
(Catalogue of Federal Domestic
Assistance Program Nos. 93.233,
National Center for Sleep Disorders
Research; 93.837, Heart and Vascular
Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood
Diseases and Resources Research,
National Institutes of Health, HHS)
Dated: May 29, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11982 Filed 6–2–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R4–ES–2020–N066;
FXES11140400000–201–FF04E00000]
Endangered Species; Recovery Permit
Applications
Fish and Wildlife Service,
Interior.
ACTION: Notice of receipt of permit
applications; request for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service, have received
applications for permits to conduct
activities intended to enhance the
propagation or survival of endangered
species under the Endangered Species
Act of 1973, as amended. We invite the
public and local, State, Tribal, and
Federal agencies to comment on these
applications. Before issuing any of the
requested permits, we will take into
consideration any information that we
receive during the public comment
period.
DATES: We must receive written data or
comments on the applications by July 6,
2020.
ADDRESSES: Reviewing Documents:
Documents and other information
submitted with the applications are
available for review, subject to the
requirements of the Privacy Act and
Freedom of Information Act. Submit a
request for a copy of such documents to
Karen Marlowe (see FOR FURTHER
INFORMATION CONTACT).
Submitting Comments: If you wish to
comment, you may submit comments by
one of the following methods:
• U.S. mail: U.S. Fish and Wildlife
Service Regional Office, Ecological
Services, 1875 Century Boulevard,
Atlanta, GA 30345 (Attn: Karen
Marlowe, Permit Coordinator).
• Email: permitsR4ES@fws.gov.
Please include your name and return
address in your email message. If you do
not receive a confirmation from the U.S.
SUMMARY:
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
34215
Fish and Wildlife Service that we have
received your email message, contact us
directly at the telephone number listed
in FOR FURTHER INFORMATION CONTACT.
FOR FURTHER INFORMATION CONTACT:
Karen Marlowe, Permit Coordinator,
404–679–7097 (telephone), karen_
marlowe@fws.gov (email), or 404–679–
7081 (fax). Individuals who are hearing
or speech impaired may call the Federal
Relay Service at 1–800–877–8339 for
TTY assistance.
We invite
review and comment from local, State,
and Federal agencies and the public on
applications we have received for
permits to conduct certain activities
with endangered and threatened species
under section 10(a)(1)(A) of the
Endangered Species Act of 1973, as
amended (ESA; 16 U.S.C. 1531 et seq.),
and our regulations in the Code of
Federal Regulations (CFR) at 50 CFR
part 17. With some exceptions, the ESA
prohibits activities that constitute take
of listed species unless a Federal permit
is issued that allows such activities. The
ESA’s definition of ‘‘take’’ includes
hunting, shooting, harming, wounding,
or killing, and also such activities as
pursuing, harassing, trapping, capturing,
or collecting.
A recovery permit issued by us under
section 10(a)(1)(A) of the ESA
authorizes the permittee to conduct
activities with endangered or threatened
species for scientific purposes that
promote recovery or for enhancement of
propagation or survival of the species.
These activities often include such
prohibited actions as capture and
collection. Our regulations
implementing section 10(a)(1)(A) for
these permits are found at 50 CFR 17.22
for endangered wildlife species, 50 CFR
17.32 for threatened wildlife species, 50
CFR 17.62 for endangered plant species,
and 50 CFR 17.72 for threatened plant
species.
SUPPLEMENTARY INFORMATION:
Permit Applications Available for
Review and Comment
Proposed activities in the following
permit requests are for the recovery and
enhancement of propagation or survival
of the species in the wild. The ESA
requires that we invite public comment
before issuing these permits.
Accordingly, we invite local, State,
Tribal, and Federal agencies and the
public to submit written data, views, or
arguments with respect to these
applications. The comments and
recommendations that will be most
useful and likely to influence agency
decisions are those supported by
quantitative information or studies.
E:\FR\FM\03JNN1.SGM
03JNN1
Agencies
[Federal Register Volume 85, Number 107 (Wednesday, June 3, 2020)]
[Notices]
[Pages 34214-34215]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11982]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Career Development Program to Promote
Diversity in Health Research (K01).
Date: July 1, 2020.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: NIH/NHLBI, 6705 Rockledge Drive, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Zhihong Shan, Ph.D., MD, Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7985,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Catalyze Review for Small Molecules
and Biologics.
Date: July 14, 2020.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: NIH/NHLBI, 6705 Rockledge Drive, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Melissa E. Nagelin, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-R, Bethesda, MD 20892, (301) 827-7951,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; PPG Special Emphasis Panel.
Date: July 16, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health (NIH), Rockledge 1, 6705
Rockledge Drive, Bethesda, MD 22192 (Telephone Conference Call).
[[Page 34215]]
Contact Person: Stephanie J. Webb, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 208-V, Bethesda, MD 20892, (301) 827-7992,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Mentored Career Development Awards--
K23, K24, K99.
Date: July 16, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, RKLI, 6705 Rockledge
Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Lindsay M. Garvin, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-Y, Bethesda, MD 20892, (301) 827-7911,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Diversity Education Program.
Date: July 20, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Shelley S. Sehnert, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-T, Bethesda, MD 20892-7924, (301) 827-7984,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Short Term Institutional Training Awards.
Date: July 23, 2020.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20872 (Telephone Conference Call).
Contact Person: Tony L. Creazzo, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 207-Q, Bethesda, MD 20892-7924, (301) 827-7913,
[email protected].
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; R35 Outstanding Investigator Award.
Date: July 28-29, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: NIH/NHLBI, 6705 Rockledge Drive, Bethesda, MD 20814
(Telephone Conference Call).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
209-B, Bethesda, MD 20892, (301) 827-7953, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National
Center for Sleep Disorders Research; 93.837, Heart and Vascular
Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood
Diseases and Resources Research, National Institutes of Health, HHS)
Dated: May 29, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-11982 Filed 6-2-20; 8:45 am]
BILLING CODE 4140-01-P